Want to see HK:1355 full AI Analyst Report?
Top Page
Legend Strategy International Holdings Group Co., Ltd.
(1355)
Select Model
Select Model
Rating:49Neutral
Price Target:
HK$0.24
▲(67.86% Upside)
Action:Reiterated
Date:09/22/26
Overall score is held down primarily by very weak financial performance—multi-year losses, negative equity, and a 2025 shift to meaningful cash burn—despite supportive technical momentum with price trading above major moving averages. Valuation is also a drag because the company is loss-making (negative P/E) and offers no stated dividend yield.
Positive Factors
Revenue Rebound
The 2025 revenue rebound and positive reported growth indicate that the company retains some ability to restore top-line activity after a weaker year. If maintained, this provides a base for operating improvement, although the benefit depends on reversing the current margin deterioration.
Negative Factors
Persistent Deep Losses
Multi-year losses show that the business has not established sustainable profitability, while the approximately -85% 2025 net margin indicates severe earnings pressure. Continued losses can consume financial resources and make any revenue recovery less valuable unless margins improve materially.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Rebound
The 2025 revenue rebound and positive reported growth indicate that the company retains some ability to restore top-line activity after a weaker year. If maintained, this provides a base for operating improvement, although the benefit depends on reversing the current margin deterioration.
Read all positive factors
Legend Strategy International Holdings Group Co., Ltd. (1355) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$422.35M
Dividend YieldN/A
Average Volume (3M)1.48M
Price to Earnings (P/E)―
Beta (1Y)0.75
Revenue Growth8.34%
EPS Growth80.94%
CountryHK
Employees94
SectorConsumer Cyclical
Sector Strength84
IndustryTravel Lodging
Share Statistics
EPS (TTM)-0.01
Shares Outstanding1,789,597,800
10 Day Avg. Volume1,954,000
30 Day Avg. Volume1,475,333
Financial Highlights & Ratios
PEG Ratio-2.47
Price to Book (P/B)-3.42
Price to Sales (P/S)2.35
P/FCF Ratio-2.43
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Legend Strategy International Holdings Group Co., Ltd. Business Overview & Revenue Model
Company Description
Legend Strategy International Holdings Group Company Limited, an investment holding company, engages in the accommodation operation and consultancy business in the People’s Republic of China. It also provides property facilities management, franch...
Legend Strategy International Holdings Group Co., Ltd. Financial Statement Overview
Summary
Income Statement
18
Very Negative
Balance Sheet
8
Very Negative
Cash Flow
22
Negative
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 50.95M | 51.30M | 40.68M | 67.66M | 63.00M | 70.56M |
| Gross Profit | -1.44M | 1.11M | 21.67M | 45.35M | 6.88M | 15.63M |
| EBITDA | -23.00M | -20.66M | 25.66M | -23.72M | 21.91M | 38.05M |
| Net Income | -8.90M | -43.53M | -21.12M | -38.18M | -7.79M | 4.98M |
Balance Sheet | ||||||
| Total Assets | 71.51M | 80.44M | 75.05M | 127.32M | 196.17M | 240.18M |
| Cash, Cash Equivalents and Short-Term Investments | 1.09M | 2.44M | 13.86M | 4.26M | 6.35M | 17.05M |
| Total Debt | 101.91M | 162.19M | 164.99M | 181.60M | 175.86M | 203.62M |
| Total Liabilities | 124.37M | 183.34M | 180.40M | 210.06M | 217.04M | 242.16M |
| Stockholders Equity | -14.39M | -35.25M | -42.35M | -36.35M | 2.18M | 12.32M |
Cash Flow | ||||||
| Free Cash Flow | -11.50M | -49.60M | 24.01M | 34.51M | 6.41M | 14.06M |
| Operating Cash Flow | -4.72M | -32.69M | 24.27M | 35.16M | 9.35M | 30.40M |
| Investing Cash Flow | -29.05M | -29.64M | -250.00K | -644.00K | -2.93M | -16.31M |
| Financing Cash Flow | 22.89M | 50.81M | -11.98M | -34.94M | -19.01M | -19.81M |
Legend Strategy International Holdings Group Co., Ltd. Technical Analysis
Positive
0.14
Price Trends
0.19
Positive
0.16
Positive
0.14
Positive
Market Momentum
0.01
Negative
69.62
Neutral
108.79
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1355, the sentiment is Positive. The current price of 0.14 is below the 20-day moving average (MA) of 0.21, below the 50-day MA of 0.19, and above the 200-day MA of 0.14, indicating a bullish trend. The MACD of 0.01 indicates Negative momentum. The RSI at 69.62 is Neutral, neither overbought nor oversold. The STOCH value of 108.79 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:1355.
Legend Strategy International Holdings Group Co., Ltd. Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | HK$1.70B | 17.30 | 2.28% | 2.11% | 3.53% | -7.42% | |
68 Neutral | HK$768.85M | 2.54 | 8.45% | 5.53% | 6.80% | 67.22% | |
62 Neutral | HK$608.40M | 16.19 | 0.90% | 0.77% | 6.29% | ― | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
51 Neutral | HK$205.08M | -0.25 | -10.26% | 2.88% | 63.78% | 49.79% | |
50 Neutral | HK$337.04M | -0.69 | -6.04% | 3.48% | 49.29% | 79.61% | |
49 Neutral | HK$422.35M | -16.86 | 35.86% | ― | 8.34% | 80.94% |
* Consumer Cyclical Sector Average
HK:1355
Legend Strategy International Holdings Group Co., Ltd.
0.24
0.13
129.13%
HK:0184
Keck Seng Investments (Hong Kong)
2.26
0.12
5.56%
HK:0201
Magnificent Hotel Investments Limited
0.07
>-0.01
-2.86%
HK:1221
Sino Hotels (Holdings) Ltd.
1.42
<0.01
0.57%
HK:0617
Paliburg Holdings Limited
0.18
-0.09
-31.85%
HK:0078
Regal Hotels International Holdings Limited
0.38
-0.22
-37.50%
Legend Strategy International Holdings Group Co., Ltd. Corporate Events
Biosysen Sets Dilution Protections on HK$50 Million Convertible Bonds
Sep 22, 2026
Biosysen Limited, formerly known as Legend Strategy International Holdings Group Co., Ltd., is a Cayman Islands–incorporated company listed in Hong Kong that uses convertible bonds as part of its financing strategy. Its HK$50 million bond is...
Biosysen Raises HK$39 Million Through Fully Placed Rights Issue to Fund R&D
Sep 7, 2026
Biosysen Limited, formerly Legend Strategy International Holdings Group Co., Ltd., is a Hong Kong-listed company incorporated in the Cayman Islands and currently emphasizing research and development initiatives. The firm plans to deploy new capita...
Biosysen Limited Publishes Unaudited Interim Results for First Half of 2026
Aug 31, 2026
Biosysen Limited has released its unaudited condensed consolidated interim results for the six months ended 30 June 2026, prepared in line with Hong Kong Stock Exchange listing rules. The interim report, reviewed by the board’s audit committ...
Biosysen Rights Issue Undersubscribed; Unplaced Shares to Be Marketed via Compensatory Placing
Aug 25, 2026
Biosysen Limited has reported the results of its rights issue, launched on the basis of one rights share for every two existing shares at a subscription price of HK$0.068 per share. The offer comprised 596,532,580 rights shares, all available to q...
Biosysen forecasts swing to profit on lease-termination gain
Aug 24, 2026
Biosysen Limited has issued a positive profit alert indicating that it expects to swing to a net profit of about HK$20 million for the six months ended 30 June 2026, compared with a loss of approximately HK$13.5 million a year earlier. The improve...
Biosysen Sets Board Meeting to Review Interim Results and Potential Dividend
Aug 19, 2026
Biosysen Limited has scheduled a board meeting for 31 August 2026 to review and approve the unaudited interim results of the company and its subsidiaries for the six months ended 30 June 2026. The meeting will also consider a possible recommendati...
Biosysen Completes HK$50 Million Convertible Bond Issue, Paving Way for Ownership Shift
Aug 5, 2026
Biosysen Limited has completed the issuance of HK$50 million in convertible bonds to a major shareholder-linked subscriber, with the subscription price settled through a set-off against an existing loan, fully discharging the company’s repay...
Biosysen Seeks Fivefold Increase in Authorised Share Capital to Support Growth
Aug 5, 2026
Biosysen Limited has proposed increasing its authorised share capital from HK$20 million to HK$100 million, raising the number of authorised shares from 2 billion to 10 billion. The additional 8 billion shares, if issued, will rank pari passu with...
Biosysen Seeks Fivefold Increase in Authorised Share Capital Ahead of August EGM
Aug 4, 2026
Biosysen Limited has called an extraordinary general meeting to seek shareholder approval for a substantial increase in its authorised share capital from HK$20 million to HK$100 million, raising the number of shares from 2 billion to 10 billion. T...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.